Name | Sarafotoxin S6c |
---|---|
Synonyms |
MFCD00133969
SRTX-c Sarafotoxin S 6c Sarafotoxin 6c |
Description | Sarafotoxin S6c (SRTX-c) is a potent endothelin-B receptor agonist. Sarafotoxin S6c can cause vasoconstriction in both endothelium-intact and endothelium-denuded vessels[1]. |
---|---|
Related Catalog | |
Target |
Endothelin-B receptor[1] |
In Vivo | Sarafotoxin S6c can cause vasoconstriction in both endothelium-intact and endothelium-denuded vessels[1]. Animal Model: Male Wister rats, exposed to 10% O2 [chronic hypoxic (CH) rats] or room air (control rats) for 2 weeks[1] Dosage: 1 pM-1 mM Administration: Result: Chronic hypoxia had effect on the sensitivity of the main pulmonary arteries to SCS6c, and small vasoconstrictor responses to were evident. Caused vasoconstriction with a maximum response 30% of that to ET-1 in both endothelium-intact and endothelium-denuded vessels. |
Molecular Formula | C103H147N27O37S5 |
---|---|
Molecular Weight | 2515.75000 |
Exact Mass | 2513.91000 |
PSA | 1172.52000 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |